Mercury exposure increases circulating net matrix metalloproteinase (MMP)-2 and MMP-9 activities

Basic and Clinical Pharmacology and Toxicology

Volumn 105, Issue 4, 2009, Pages 281-288

  Jacob Ferreira, Anna L B ^a   Passos, Carlos J S ^b   Jordão, Alceu A ^b   Fillion, Myriam ^c   Mergler, Donna ^c   Lemire, Mélanie ^c   Gerlach, Raquel F ^b   Barbosa Jr, Fernando ^b   Tanus Santos, Jose E ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GELATINASE A; GELATINASE B; MERCURY; SELENIUM; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CROSS-SECTIONAL STUDIES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENVIRONMENTAL EXPOSURE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MERCURY; MIDDLE AGED; OXIDATIVE STRESS; REGRESSION ANALYSIS; SELENIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; YOUNG ADULT;

EID: 70349095434     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00443.x     Document Type: Article

References (60)

1. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 2002 37 : 375 536.
2. Palei AC, Sandrim VC, Cavalli RC, Tanus-Santos JE. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clin Biochem 2008 41 : 875 880.
3. Martinez ML, Lopes LF, Coelho EB, Nobre F, Rocha JB, Gerlach RF et al. Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension. J Cardiovasc Pharmacol 2006 47 : 117 122.
4. Fortuna GM, Figueiredo-Lopes L, Dias-Junior CA, Gerlach RF, Tanus-Santos JE. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism. Int J Cardiol 2007 114 : 22 7.
5. Sundstrom J, Vasan RS. Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events. Curr Opin Lipidol 2006 17 : 45 53.
6. Demacq C, Metzger IF, Gerlach RF, Tanus-Santos JE. Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers. Clin Chim Acta 2008 394 : 72 6.
7. Garvin P, Nilsson L, Carstensen J, Jonasson L, Kristenson M. Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population. PLoS ONE 2008 3 : e1774.
8. Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004 110 : 1747 1753.
9. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003 107 : 1579 1585.
10. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002 95 : 787 796.
11. Clarkson TW, Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 2006 36 : 609 662.
12. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Mercury. U.S. Department of Health and Human Services. Public Health Service, Atlanta, 1999.
13. Mergler D, Anderson HA, Chan LH, Mahaffey KR, Murray M, Sakamoto M et al. Methylmercury exposure and health effects in humans: a worldwide concern. Ambio 2007 36 : 3 11.
14. Boffetta P, Sallsten G, Garcia-Gomez M, Pompe-Kirn V, Zaridze D, Bulbulyan M et al. Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med 2001 58 : 461 466.
15. Guallar E, Sanz-Gallardo MI, van't Veer P, Bode P, Aro A, Gomez-Aracena J et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 2002 347 : 1747 1754.
16. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 2000 148 : 265 273.
17. Virtanen JK, Rissanen TH, Voutilainen S, Tuomainen TP. Mercury as a risk factor for cardiovascular diseases. J Nutr Biochem 2007 18 : 75 85.
18. Virtanen JK, Voutilainen S, Rissanen TH, Mursu J, Tuomainen TP, Korhonen MJ et al. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol 2005 25 : 228 233.
19. Jie XL, Jin GW, Cheng JP, Wang WH, Lu J, Qu LY. Consumption of mercury-contaminated rice induces oxidative stress and free radical aggravation in rats. Biomed Environ Sci 2007 20 : 84 9.
20. Wolf MB, Baynes JW. Cadmium and mercury cause an oxidative stress-induced endothelial dysfunction. Biometals 2007 20 : 73 81.
21. Nelson KK, Melendez JA. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 2004 37 : 768 784.
22. Ra HJ, Parks WC. Control of matrix metalloproteinase catalytic activity. Matrix Biol 2007 26 : 587 596.
23. Furst A. Can nutrition affect chemical toxicity? Int J Toxicol 2002 21 : 419 424.
24. Peraza MA, Ayala-Fierro F, Barber DS, Casarez E, Rael LT. Effects of micronutrients on metal toxicity. Environ Health Perspect 1998 106 (Suppl 1 203 216.
25. Passos CJ, Mergler D, Fillion M, Lemire M, Mertens F, Guimaraes JR et al. Epidemiologic confirmation that fruit consumption influences mercury exposure in riparian communities in the Brazilian Amazon. Environ Res 2007 105 : 183 193.
26. Watanabe C. Modification of mercury toxicity by selenium: practical importance? Tohoku J Exp Med 2002 196 : 71 7.
27. Chen C, Yu H, Zhao J, Li B, Qu L, Liu S et al. The roles of serum selenium and selenoproteins on mercury toxicity in environmental and occupational exposure. Environ Health Perspect 2006 114 : 297 301.
28. Passos CJ, Mergler D. Human mercury exposure and adverse health effects in the Amazon: a review. Cad Saude Publica 2008 24 (Suppl 4 503 520.
29. Lemire M, Mergler D, Fillion M, Passos CJ, Guimaraes JR, Davidson R et al. Elevated blood selenium levels in the Brazilian Amazon. Sci Total Environ 2006 366 : 101 111.
30. Lemire M, Mergler D, Huel G, Passos CJ, Fillion M, Philibert A et al. Biomarkers of selenium status in the Amazonian context: blood, urine and sequential hair segments. J Expo Sci Environ Epidemiol 2008 30 : 30.
31. CARUSO. Mercury exposure and ecosystem health in the Amazon. http://www.unites.uqam.ca/gmf/caruso/caruso.htm. 2007 (last accessed on 24 May 2008).
32. Passos CJ, Da Silva DS, Lemire M, Fillion M, Guimaraes JR, Lucotte M et al. Daily mercury intake in fish-eating populations in the Brazilian Amazon. J Expo Sci Environ Epidemiol 2008 18 : 76 87.
33. Budtz-Jorgensen E, Grandjean P, Jorgensen PJ, Weihe P, Keiding N. Association between mercury concentrations in blood and hair in methylmercury-exposed subjects at different ages. Environ Res 2004 95 : 385 393.
34. Barbosa F Jr., Gerlach RF, Tanus-Santos JE. Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations. Basic Clin Pharmacol Toxicol 2006 98 : 559 564.
35. Berglund M, Lind B, Bjornberg KA, Palm B, Einarsson O, Vahter M. Inter-individual variations of human mercury exposure biomarkers: a cross-sectional assessment. Environ Health 2005 4 : 20.
36. Palmer CD, Lewis ME, Geraghty CM, Barbosa F, Parsons PJ. Determination of lead, cadmium and mercury in blood for assessment of environmental exposure: a comparison between inductively coupled plasma-mass spectrometry and atomic absorption spectrometry. Spectrochim Acta Part B At Spectrosc 2006 61 : 980 990.
37. Goulle JP, Mahieu L, Castermant J, Neveu N, Bonneau L, Laine G et al. Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair. Reference values. Forensic Sci Int 2005 153 : 39 44.
38. Barceloux DG. Selenium. J Toxicol Clin Toxicol 1999 37 : 145 172.
39. Zachara BA, Gromadzinska J, Wasowicz W, Zbrog Z. Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review. Acta Biochim Pol 2006 53 : 663 677.
40. Gerlach RF, Uzuelli JA, Souza-Tarla CD, Tanus-Santos JE. Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Anal Biochem 2005 344 : 147 149.
41. Souza-Tarla CD, Uzuelli JA, Machado AA, Gerlach RF, Tanus-Santos JE. Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Clin Biochem 2005 38 : 410 414.
42. Gerlach RF, Demacq C, Jung K, Tanus-Santos JE. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clin Biochem 2007 40 : 119 123.
43. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978 52 : 302 310.
44. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992 267 : 4583 4591.
45. Chow AK, Cena J, Schulz R. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. Br J Pharmacol 2007 152 : 189 205.
46. Tan J, Hua Q, Xing X, Wen J, Liu R, Yang Z. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension. Hypertens Res 2007 30 : 959 963.
47. Passos CJ, Mergler D, Lemire M, Fillion M, Guimaraes JR. Fish consumption and bioindicators of inorganic mercury exposure. Sci Total Environ 2007 373 : 68 76.
48. Fillion M, Mergler D, Sousa Passos CJ, Larribe F, Lemire M, Guimaraes JR. A preliminary study of mercury exposure and blood pressure in the Brazilian Amazon. Environ Health 2006 5 : 29.
49. Agarwal R, Behari JR. Effect of selenium pretreatment in chronic mercury intoxication in rats. Bull Environ Contam Toxicol 2007 79 : 306 310.
50. Su L, Wang M, Yin ST, Wang HL, Chen L, Sun LG et al. The interaction of selenium and mercury in the accumulations and oxidative stress of rat tissues. Ecotoxicol Environ Saf 2008 70 : 483 489.
51. Derosa G, Ferrari I, D'Angelo A, Tinelli C, Salvadeo SA, Ciccarelli L et al. Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium 2008 15 : 219 224.
52. Belvisi MG, Bottomley KM. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? Inflamm Res 2003 52 : 95 100.
53. Morimoto Y, Tsuda T, Nakamura H, Hori H, Yamato H, Nagata N et al. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and extracellular matrix mRNA following exposure to mineral fibers and cigarette smoke in vivo. Environ Health Perspect 1997 105 (Suppl 5 1247 1251.
54. Ning W, Dong Y, Sun J, Li C, Matthay MA, Feghali-Bostwick CA et al. Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts. Am J Respir Cell Mol Biol 2007 36 : 480 490.
55. Raitio A, Tuomas H, Kokkonen N, Salo T, Sorsa T, Hanemaaijer R et al. Levels of matrix metalloproteinase-2, -9 and -8 in the skin, serum and saliva of smokers and non-smokers. Arch Dermatol Res 2005 297 : 242 248.
56. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000 117 : 684 694.
57. Wright JL, Tai H, Wang R, Wang X, Churg A. Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling. Am J Physiol Lung Cell Mol Physiol 2007 292 : L125 33.
58. Bonnema DD, Webb CS, Pennington WR, Stroud RE, Leonardi AE, Clark LL et al. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs). J Card Fail 2007 13 : 530 540.
59. Paczek L, Michalska W, Bartlomiejczyk I. Trypsin, elastase, plasmin and MMP-9 activity in the serum during the human ageing process. Age Ageing 2008 37 : 318 323.
60. Samnegard A, Hulthe J, Silveira A, Ericsson CG, Hamsten A, Eriksson P. Gender specific associations between matrix metalloproteinases and inflammatory markers in post myocardial infarction patients. Atherosclerosis 2008 5 : 5.